Pfizer to acquire Arena Pharmaceuticals
Pfizer will acquire all outstanding shares of Arena Pharmaceuticals for $100 per share in an all-cash transaction for a total equity value of approximately $6.7 billion. Read More
Lilly and Foghorn collaborate on novel oncology targets
Loxo Oncology at Lilly and Foghorn Therapeutics will collaborate to create novel oncology medicines by applying Foghorn's proprietary Gene Traffic Control platform. The collaboration includes Foghorn's BRM oncology program, an additional undisclosed oncology target, as well as three additional discovery programs. Read More
Accellix raises $10M from BroadOak Capital Partners
Accellix has raised $10 million from BroadOak Capital Partners. Accellix is a biotechnology company that provides flow cytometry results in a compact, easy-to-use platform for use by cell therapy companies on the manufacturing floor and at the point of need. Read More
Smart Immune, Memorial Sloan Kettering expedite development of next-gen CAR T
Smart Immune is collaborating with Memorial Sloan Kettering Cancer Center with the goal of expanding its ProTcell pipeline to address the exhaustion of T-cell therapy and fulfill unmet medical needs in the treatment of liquid and solid cancers. Read More
Illumina supports Norway's pioneering precision medicine study
Illumina announced that it is supporting a precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling in cancer therapy selection testing. Read More
Moderna launches AI academy with Carnegie Mellon University
Moderna has launched the Artificial Intelligence (AI) Academy for its employees in partnership with Carnegie Mellon University. The AI Academy is intended to empower employees to integrate AI and machine-learning solutions into every Moderna system and process to deliver mRNA medicines to patients, the company said. Read More
Lilly, Regor Therapeutics Group enter into strategic collaboration
Eli Lilly and Regor Therapeutics Group have entered into a multiyear research collaboration and licensing agreement to discover, develop, and commercialize novel therapies for metabolic disorders, including obesity and diabetes. The groups will leverage Regor's computer accelerated rational discovery platform. Read More
FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16-, 17-year-olds
The U.S. Food and Drug Administration (FDA) has amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. Specifically, the FDA authorized the use of a single booster dose for administration to individuals 16 and 17 years of age at least six months after completion of primary vaccination with the Pfizer-BioNTech COVID-19 vaccine. Read More
Life Science Investment Summit takes applications for seed-stage funding
Applied Pharmaceutical Innovation, a nonprofit life sciences institute, has partnered with Startup TNT, an Alberta-based nonprofit and startup community to build the Startup TNT Life Sciences Investment Summit, a platform for life sciences entrepreneurs and innovators seeking seed-stage funding. Read More
Interius BioTherapeutics obtains U.S. patent to support gene delivery platform
Interius BioTherapeutics announced that the U.S. Patent and Trademark Office has granted U.S. patent No. US11191784, titled "The Methods and Composition for Gene Delivery Using an Engineered Viral Particle." Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
